Dilution profile // every instrument, one screen, from SEC filings

Alamar Biosciences, Inc. (ALMR)

CIK 2104204 · all EDGAR filings →

Overall dilution risk
HIGHworst of 3 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGH$100M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
registered capacity, not remaining: amounts already taken down are not subtracted yet
Overhead supply
LOWwarrants = 0% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
LOW0% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
NOT COMPUTEDrunway not computable from latest facts
= cash vs trailing operating burn

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2026-04-302026-07-31

Latest: 69.4M shares as of Jul 31, 2026 (10-Q).

Cash runway

Not enough filing data

can’t compute a runway

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 31,251 underlying shares, as reported Apr 19, 2026 (10-Q).

Rough fully diluted estimate: 69.4M = 69.4M O/S + 31,251 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

Convertible debt on the balance sheet: $56.5M as of Jan 8, 2026, tagged only as a company-wide total.

This filer tagged totals without per-note dimensions in its 10-Q filed Aug 11, 2026, so per-note terms (maturities, individual conversion prices) live in the exhibit prose and are not parsed here.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding69.4MJul 31, 2026
+ Warrants (aggregate, as tagged) (if exercised)31,251Apr 19, 2026
Fully diluted estimate69.4M+0.0% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

Registered offering capacity on live registrations: $100.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-1Mar 27, 2026$100.0M registeredfiling →

Last 12 months: 1 executed · 4 registered.

EFFECTIVEApr 20, 2026SEC declared a registration effective — selling can beginEFFECT
EXECUTEDApr 17, 2026Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4
REGISTEREDApr 16, 2026S-1/A registration — capacity to sell shares, not a sale yetS-1/A
REGISTEREDApr 16, 2026S-1MEF registration — capacity to sell shares, not a sale yetS-1MEF
EFFECTIVEApr 16, 2026SEC declared a registration effective — selling can beginEFFECT
REGISTEREDApr 13, 2026S-1/A registration — capacity to sell shares, not a sale yetS-1/A
REGISTEREDMar 27, 2026S-1 registration — capacity to sell shares, not a sale yetS-1

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full ALMR workspace